Three scientific posters highlighting novel anti-virulence pharmacologic properties of oral ibezapolstat for C. difficile Infection; effects on toxin production, biofilm and the gut microbiome A ...
This Poster will be available on the Company’s website on the “Publications: Posters & Presentations” page under the “Our Science” tab.
Presenting your poster at a Labroots Virtual Event can provide valuable research insights and feedback from peers in the comfort of your home or office. Every Labroots virtual event features a virtual ...
TORONTO--(BUSINESS WIRE)--Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of AV-001 for the treatment of diseases associated with vascular dysfunction ...
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting Eight scientific posters demonstrate significant ...
Labroots is excited to host the 8th Annual Event in the Bioprocessing Virtual Event Series on April 1st, 2026! Bioprocessing, at its core, is the art and science of transforming raw materials into ...
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by ...
Al Ain University, in collaboration with Monash University Malaysia, organized the fourth Graduate Student Symposium in Health and Medical Sciences on ...